N

Navidea Biopharmaceuticals

14 employees

Navidea develops precision immunodiagnostic agents and immunotherapeutics for patients with cancer, autoimmune, and infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Biopharma

Date founded

1983

Funding rounds raised

Total raised

$60M

from 2 investors over 2 rounds

N

Navidea Biopharmaceuticals raised $60M on May 11, 2015

Investors: CRG LP

N

Navidea Biopharmaceuticals raised $30M on March 6, 2014

Investors: Oxford Finance LLC

FAQ